In contrast, Behrens et al. demonstrated that CD163 expression was increased in the bone-marrow aspirates of 15 sJIA patients, of which two patients were diagnosed clinically with overt MAS, thereby suggesting that this increase is not exclusive to MAS patients. Here, CD163 is linked to macrophage activation syndrome.